Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial
- DOI
- 10.1161/strokeaha.126.056558
- Published
- 2026-08
- Container
- Stroke
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/strokeaha.126.056558,
title = {Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial},
author = {Xinyan Hu and Qianmei Jiang and Ning Wang and Qi Liu and Shilin Li and Pengzhan Wang and Chen Ling and Anxin Wang and Zhe Zhang and Jianying Cao and Xinjian Yang and Yongjun Wang and Xuewei Xie and Jing Jing and Lian Liu},
year = {2026},
journal = {Stroke},
doi = {10.1161/strokeaha.126.056558},
url = {https://doi.org/10.1161/strokeaha.126.056558}
}RIS
TY - JOUR TI - Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial AU - Xinyan Hu AU - Qianmei Jiang AU - Ning Wang AU - Qi Liu AU - Shilin Li AU - Pengzhan Wang AU - Chen Ling AU - Anxin Wang AU - Zhe Zhang AU - Jianying Cao AU - Xinjian Yang AU - Yongjun Wang AU - Xuewei Xie AU - Jing Jing AU - Lian Liu PY - 2026 JO - Stroke DO - 10.1161/strokeaha.126.056558 UR - https://doi.org/10.1161/strokeaha.126.056558 ER -
APA
Hu, X., Jiang, Q., Wang, N., Liu, Q., Li, S., Wang, P., Ling, C., Wang, A., Zhang, Z., Cao, J., Yang, X., Wang, Y., Xie, X., Jing, J., & Liu, L. (2026). Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial. Stroke. https://doi.org/10.1161/strokeaha.126.056558
Source records
- crossref · retrieved 2026-09-26T22:34:29.002Z